nach oben

Critical Care

Erschienen in:

Open Access 01.12.2016 | Research

The value of blood lactate kinetics in critically ill patients: a systematic review

verfasst von: Jean-Louis Vincent, Amanda Quintairos e Silva, Lúcio Couto Jr, Fabio S. Taccone

Erschienen in: Critical Care | Ausgabe 1/2016

Abstract

Background

The time course of blood lactate levels could be helpful to assess a patient’s response to therapy. Although the focus of published studies has been largely on septic patients, many other studies have reported serial blood lactate levels in different groups of acutely ill patients.

Methods

We performed a systematic search of PubMed, Science Direct, and Embase until the end of February 2016 plus reference lists of relevant publications. We selected all observational and interventional studies that evaluated the capacity of serial blood lactate concentrations to predict outcome. There was no restriction based on language. We excluded studies in pediatric populations, experimental studies, and studies that did not report changes in lactate values or all-cause mortality rates. We separated studies according to the type of patients included. We collected data on the number of patients, timing of lactate measurements, minimum lactate level needed for inclusion if present, and suggested time interval for predictive use.

Results

A total of 96 studies met our criteria: 14 in general ICU populations, five in general surgical ICU populations, five in patients post cardiac surgery, 14 in trauma patients, 39 in patients with sepsis, four in patients with cardiogenic shock, eight in patients after cardiac arrest, three in patients with respiratory failure, and four in other conditions. A decrease in lactate levels over time was consistently associated with lower mortality rates in all subgroups of patients. Most studies reported changes over 6, 12 or 24 hrs, fewer used shorter time intervals. Lactate kinetics did not appear very different in patients with sepsis and other types of patients. A few studies suggested that therapy could be guided by these measurements.

Conclusions

The observation of a better outcome associated with decreasing blood lactate concentrations was consistent throughout the clinical studies, and was not limited to septic patients. In all groups, the changes are relatively slow, so that lactate measurements every 1–2 hrs are probably sufficient in most acute conditions. The value of lactate kinetics appears to be valid regardless of the initial value.

Background

Since the early studies by Weil and others [1‐3], blood lactate concentrations have been used widely as a marker of altered tissue perfusion in critically ill patients [4]. In physiological conditions, about 1500 mmol of lactate is produced daily from various organs, including the muscle, the intestine, the red blood cells, the brain, and the skin [5]. Lactate is metabolized by the liver (about 60 %), the kidneys (about 30 %), and other organs [5]. The normal blood lactate concentration is around 1 mEq/l [6]. Even minor increases in lactate concentrations to >1.5 mEq/l are associated with higher mortality rates [6, 7]. The exact pathophysiologic mechanisms of hyperlactatemia have been much debated, because the condition does not always simply reflect the development of anaerobic metabolism [8]. In sepsis in particular, metabolic alterations can contribute to elevated blood lactate concentrations, including increased glycolysis, catecholamine-stimulated Na–K pump activity, alterations in pyruvate dehydrogenase activity, and reduced lactate clearance primarily as a result of liver hypoperfusion. Regardless of these mechanisms, hyperlactatemia is a hallmark characteristic of shock states [4, 9] and the degree of increase in lactate concentrations is directly related to the severity of the shock state and to mortality rates [10, 11].

As for the blood levels of any substance, elevated lactate levels can be the result of increased production, reduced elimination, or both. A dynamic evaluation of serial lactate concentrations may thus be more informative than a single value. This concept of repeating blood lactate concentrations over time as an indicator of response to therapy was first proposed in 1983 [12], based on an idea raised after a publication by Orringer et al. in 1977 [13] showing that the decrease in lactate levels after cessation of grand mal seizures was actually quite rapid, with a half-life of about 50 % in 1 hr. Many studies have since emphasized that changes in lactate over the first hrs of treatment may represent a valuable monitoring tool. Some studies have even proposed integrating changes in lactate concentrations as a target in therapeutic protocols [14‐17] or including them as one of the sepsis resuscitation “bundles” [18]. A number of investigators have used the term “lactate clearance” to describe decreasing lactate levels, but this is incorrect for two reasons. The first is that the changes in lactate concentrations over time reflect changes in production and in elimination. The decrease in lactate over time may reflect decreased (over)production more than increased clearance by the liver and other organs [19, 20]. The specific study of lactate clearance would require intravenous injection of radiolabeled lactate, as has been done in several studies [21, 22]. The second reason why use of the term is incorrect is that “clearance” or “elimination” implies a progressive normalization of blood lactate concentrations, which is too simplistic. Blood lactate concentrations can have a complex evolution and may even increase over time (Fig. 1), a situation that one should then call “negative lactate clearance”.

We performed a literature search on this subject to address several questions. First, is the observation of a better prognosis with decreasing lactate concentrations a consistent finding in all types of critically ill patient? Second, although some studies have suggested that repeated lactate measurements may be particularly useful in sepsis, can similar observations be made in other acute disease states or even in heterogeneous groups of critically ill patients? Third, how fast should lactate concentrations decrease in optimal conditions and is there any particular time interval that could be recommended? Fourth, some studies in emergency medicine considered only patients with lactate values > 4 mEq/l as an at-risk population, but is this approach valid? In other words, is the study of lactate kinetics more useful when lactate concentrations exceed a given value?

Methods

We searched databases of PubMed, Science Direct, and Embase until the end of February 2016 to identify studies that evaluated the capacity of serial blood lactate concentrations to predict outcome, using the search terms “Lactate levels” OR “lactate clearance” AND “shock” OR “critically ill” AND “mortality”. We included original prospective or retrospective clinical studies. There was no restriction based on language. We excluded studies in pediatric populations, experimental studies, case reports, and studies that did not report changes over time in lactate values or relationship of changes in lactate concentrations to all-cause mortality rates. We had no restriction on the initial location in the hospital (e.g., ICU, trauma unit, emergency room, operating room). We also checked the reference lists of included articles to capture any references missed during the search. We classified the different adult populations into general ICU patients, general surgical ICU patients, cardiac surgery patients, trauma patients, patients with sepsis, patients with cardiogenic shock, post-cardiac arrest patients, patients with respiratory failure, and others.

Results

A total of 96 studies met our inclusion criteria (Fig. 2, Table 1).

Table 1

Included studies according to population type

	First author, year [reference]	Number of patients	Study design	Initial minimum lactate for patient inclusion	Timing of measurements	Suggested time interval	Comments
	General ICU/emergency department
	Observational
1.	Vincent, 1983 [12]	17	Prospective	≥4	Every 20 min during first 2 h of ICU treatment	1 h	Decrease >10 % associated with survival
2.	Cowan, 1984 [23]	30	Prospective	–	3 h, 24 h	3 h	Change in lactate predictive of outcome but less so than simple hemodynamic variables
3.	Suistomaa, 2000 [24]	100	Prospective	–	Every 2 h for 24 h	6 h	Failure to decrease lactate at 6 h associated with higher mortality
4.	Jansen, 2008 [31]	106	Prospective	–	Variable (at ambulance pickup and at ER arrival)	—	Decrease in lactate independently associated with decreased hazard of death
5.	Wang, 2009 [25]	101	NR	≥2	12 h, 24 h	12 h	Decrease ≤10 % associated with increased mortality
6.	Jansen, 2009 [26]	394	Prospective	–	12 h, 24 h	12 h	Decrease in lactate only of prognostic value in patients with sepsis
7.	Krishna, 2009 [27]	50	Prospective	–	12 h, 24 h, 36 h	24 h, 36 h	Decreasing levels associated with survival
8.	Soliman, 2010 [28]	433	Prospective	–	24 h, 48 h	24 h	Higher lactate concentrations at 24 and 48 h after admission associated with decreased survival
9.	Nichol, 2010 [6]	7155	Retrospective	–	Variable	24 h	Time-weighted average lactate over 24 h independent predictor of mortality
10.	Nichol, 2011 [10]	5041	Retrospective	–	Variable	24 h	Time-weighted average lactate and change in lactate over 24 h independent predictors of hospital mortality
11.	van Beest, 2013 [29]	2251	Retrospective	–	Variable	6 h	Normalization of lactate <6 h after ICU admission associated with better hospital survival than normalization of lactate >6 hrs
12.	Zhang, 2014 [30]	6291	Retrospective	>2	Variable	Variable	Normalization and speed of normalization related to outcome
13.	Haas, 2016 [11]	400	Retrospective	>10	Variable	12 h	No decrease in lactate over 12 h associated with increased mortality
	Interventional
14.	Jansen, 2010 [15]	348	Prospective	≥3.0	2 h	8 h	Objective was to decrease lactate by 20 % or more per 2 h for the initial 8 h of ICU stay. Lactate-guided therapy was independently associated with reduced hospital mortality
	Surgical ICU
15.	McNelis, 2001 [32]	95	Retrospective	–	8-h intervals until lactate normalized	Variable	Time to lactate normalization predictive of outcome
16.	Husain, 2003 [33]	137	Retrospective	–	Variable	Variable	Time to lactate normalization independent predictor of mortality
17.	Meregalli, 2004 [34]	44	Prospective	–	12 h, 24 h, 48 h	48 h	Blood lactate concentrations decreased with time in survivors, but remained stable in nonsurvivors
18.	Cardinal Fernandez, 2009 [35]	108	Prospective	>2	6 h	6 h	Decrease in lactate by >40 % associated with increased survival
19.	Ibrahim, 2013 [36]	322	Prospective	–	8 h, 16 h, 24 h	16 h	Percent change in blood lactate at 16 h independent predictor of postoperative mortality
	Cardiac surgery
20.	Lindsay, 2013 [37]	1291	Retrospective	–	Variable	Variable	Longer predicted time to reach normal lactate (<1.5 mmol/l) associated with increased mortality
21.	Hajjar, 2013 [38]	502	Prospective	–	6 h, 12 h	6 h, 12 h	Failure to decrease lactate associated with major complications, including death
22.	Park, 2014 [39]	115	Retrospective	–	6 h, 12 h, 24 h	6 h, 12 h, 24 h	Lack of decrease in lactate predictive of mortality
23.	Lopez-Delgado, 2015 [40]	2935	Prospective	–	6 h, 12 h, 24 h	24 h	Later peak in lactate associated with higher hospital and long-term mortality
24.	Li, 2015 [41]	123	Retrospective	–	6 h, 12 h	12 h	Lactate decrease predictive of in-hospital mortality in patients receiving ECMO
	Trauma
	Observational
25.	Abramson, 1993 [42]	76	Prospective	–	8 h, 16 h, 24 h, 36 h, 48 h	24 h	Normalization of lactate by 24 h associated with 100 % survival
26.	Manikis, 1995 [43]	129	Retrospective	–	At least three times a day	Variable	Duration of hyperlactatemia correlated with the development of organ failure but not with mortality
27.	Holm, 2000 [44]	21	Prospective	–	12 h, 24 h, 48 h, 72 h	Variable	Decreasing lactate levels associated with survival
28.	Cerovic, 2003 [45]	98	Prospective	–	Twice daily during first 2 days and once daily during next 3 days	Variable	Reduced lactate levels in survivors
29.	Kamolz, 2005 [46]	166	Prospective	–	Variable	24 h	Higher mortality in patients with initial lactate > 2 mmol/l if lactate not normalized at 24 h
30.	Billeter, 2009 [47]	1032	Retrospective	–	Variable	24 h	Delayed or absent decrease in lactate associated with infectious complications but not mortality
31.	Regnier, 2012 [48]	281	Prospective	–	2 h, 4 h	2 h	Early normalization of lactate independent predictor of survival
32.	Dubendorfer, 2013 [49]	724	Retrospective	–	Variable	Variable	In patients without traumatic brain injury, decrease in lactate impaired in nonsurvivors
33.	Odom, 2013 [50]	623	Retrospective	≥4	6 h	6 h	Lower decrease in lactate at 6 h independently predictive of increased risk of death
34.	Heinonen, 2014 [51]	610	Retrospective	–	Variable	Variable	Failure to normalize lactate associated with increased mortality
35.	Freitas, 2015 [52]	117	Retrospective	–	6 h	6 h	No correlation between decrease in lactate and mortality
36.	Dezman, 2015 [53]	3887	Retrospective	≥3	Variable	Variable	No decrease in lactate independent predictor of 24-h mortality
	Interventional
37.	Blow, 1999 [55]	79	Retrospective	–	Variable	24 h	Failure to decrease lactate associated with increased mortality
38.	Claridge, 2000 [56]	364	Prospective	–	Variable	12 h	Increase in infections, length of stay, and mortality if lactate did not normalize by 12 h
	Sepsis
	Observational
39.	Bakker, 1991 [57]	48	Prospective	>2	Variable	Variable	Only survivors had a significant decrease in blood lactate concentrations during the course of septic shock
40.	Friedman, 1995 [58]	35	Prospective	>2	4 h, 24 h	Variable	Lactate remained high in nonsurvivors and progressively decreased in survivors
41.	Bernardin, 1996 [59]	32	Prospective	–	24 h	24 h	Greater decrease in lactate in survivors
42.	Marecaux, 1996 [60]	38	Prospective	>2	24 h, 48 h	24 h, 48 h	Greater decrease in lactate in survivors
43.	Bakker, 1996 [61]	87	Prospective	>2	Variable	Variable	Duration of lactic acidosis best discriminant of survival
44.	Kobayashi, 2001 [62]	22	Prospective	–	Every 4 hours for 4 days	Variable	Decrease in lactate associated with survival
45.	Nguyen, 2004 [63]	111	Prospective	–	6 h	6 h	Decrease in lactate ≥10 % associated with lower 60-day mortality
46.	Nguyen, 2007 [64]	330	Prospective	–	Variable	6 h	Decreased odds ratio for mortality in patients with decreased lactate
47.	Phua, 2008 [65]	72	Prospective	–	24 h, 48 h	24 h	Increase in lactate predictive of mortality
48.	Yang, 2009 [66]	105	Prospective	–	6 h, 24 h, 72 h	6 h	Decrease in lactate at 6 h ≥30 % was independent predictor of survival
49.	Arnold, 2009 [67]	166	Retrospective	–	6 h	6 h	Lactate decrease by less than 10 % independent predictor of in-hospital death
50.	Nguyen, 2010 [68]	220	Retrospective	–	6 h	6 h	Larger decrease in lactate associated with decreased mortality up to 12 months
51.	Nguyen, 2011 [18]	556	Prospective	–	12 h	12 h	Any decrease in lactate within 12 h from baseline or an initial lactate <2 mmol/l independently associated with reduced mortality
52.	Puskarich, 2012 [69]	203	Retrospective analysis of data from [16]	–	2 h, 4 h, 6 h	6 h	≥10 % decrease in lactate during resuscitation associated with decreased mortality
53.	Zanaty, 2012 [70]	53	Prospective	–	6 h	6 h	<15 % decrease in lactate independent predictor of mortality
54.	Puskarich, 2013 [71]	187	Retrospective analysis of data from [16]	–	At least two lactate measurements in first 6 h	6 h	Lactate normalization in 6 h stronger independent predictor of survival than decrease in lactate by ≥50 %
55.	Walker, 2013 [72]	78	Retrospective	–	6 h	6 h	Decrease in lactate independently associated with mortality, with optimal cut-off of 36 %
56.	Liu, 2013 [73]	9190	Retrospective	≥2	4 h, 8 h, 12 h	12 h	Reduced mortality in patients with more than 60 % lactate improvement at 12 h.
57.	Marty, 2013 [74]	94	Prospective	–	6 h, 12 h, 24 h	24 h	Decrease in lactate at 24 h independently correlated to survival
58.	Park, 2014 [75]	25	Prospective	–	6 h, 12 h, 18 h, 24 h, 48 h	48 h	Normalization independent predictor of survival
59.	Permpikul, 2014 [76]	51	Prospective	–	6 h	6 h	Lactate decrease associated with reduced 28-day mortality
60.	Bao, 2015 [77]	94	Retrospective	–	3 h, 6 h, 24 h	24 h	24-h lactate decrease predictive of outcome
61.	Galbois, 2015 [78]	42	Prospective	–	6 h, 12 h, 18 h, 24 h	6 h	Lesser decrease in lactate associated with 14-day mortality
62.	Lee, 2015 [79]	109	Retrospective	>3.3	6 h, 24 h, 48 h	6 h, 24 h, 48 h	Decrease in lactate of <10 % in the first 6 h, 24 h, and 48 h independently associated with mortality
63.	Dettmer, 2015 [17]	243	Retrospective	≥4	Variable	Variable	Greater reduction in lactate associated with decreased 28-day mortality
64.	Lokhandwala, 2015 [80]	74	Retrospective	≥4	Variable	Variable	Lactate decrease < 4 mmol/l associated with increased hospital morality
65.	Wang, 2015 [81]	115	Prospective	–	6 h, 12 h, 18 h, 24 h	24 h	Lower lactate area score and percentage decrease in lactate associated with increased mortality
66.	Bhat, 2015 [82]	207	Retrospective	–	Variable	Variable	Higher mortality in patients with no decrease in lactate
67.	Chertoff, 2016 [83]	229	Retrospective	–	24-48 h	24-48 h	Lower decrease in plasma lactate 24–48 h after initiation of treatment was associated with higher 30-day mortality
68.	Drumheller, 2016 [84]	411	Retrospective	≥4	Variable	Variable	Decrease in lactate independently associated with decreased risk of death
69.	He, 2016 [85]	84	Prospective	–	8 h	8 h	Patients with lactate decrease ≥10 % had lower ICU mortality than those with lactate decrease <10 %
70.	Ha, 2016 [86]	208		–	6 h, 24 h	24 h	Low decrease in lactate at 6 and 24 h independently associated with hospital mortality, but 24-h lactate decrease had higher discriminatory power
71.	Bolvardi, 2016 [87]	90	Prospective	–	6 h	6 h	Lactate decrease <10 % associated with increased mortality
72.	Amir, 2016 [88]	202	Prospective	–	6 h	6 h	Lactate decrease ≥10 % not associated with mortality
	Interventional
73.	Jones, 2010 [16]	300	Prospective	–	Variable	Variable	No differences in in-hospital mortality using management to normalize lactate compared with management to normalize ScvO₂
74.	Tian, 2012 [89]	62	Prospective	–	Variable	48 h	28-day mortality rates lower in patients with 30 % decrease in lactate target than in those with 10 % decrease in lactate target and controls
75.	Yu, 2013 [90]	50	Prospective	–	3 h, 6 h, 72 h	6 h, 72 h	No differences in in-hospital mortality using management targeted at 10 % lactate decrease compared with management to normalize ScvO₂
76.	Lyu, 2015 [91]	100	Prospective	–	1 h, 2 h, 3 h, 4 h, 5 h, 6 h	6 h	28-day mortality independently associated with lactate decrease <10 %
77.	Kuan, 2016 [92]	122	Prospective	≥3	Variable	3 h	Lactate decrease >20 % associated with decreased mortality
	Cardiogenic shock
78.	Attana, 2012 [93]	51	Prospective	–	12 h	12 h	Decrease in lactate by <10 % predicts higher risk of death
79.	Attana, 2013 [94]	63	Prospective	–	12 h	12 h	Nonsurvivors had smaller decrease in lactate
80.	Park, 2014 [95]	96	Retrospective	–	Variable	48 h	Lactate decrease <70 % independent predictor of hospital mortality
81.	Guenther, 2014 [96]	41	retrospective	–	Variable	6 h	Increased lactate concentrations at 6 h associated with nonsurvival after ECMO
	Cardiac arrest
82.	Kliegel, 2004 [97]	394	Retrospective	–	24 h, 48 h	48 h	Persistent hyperlactatemia predictive or poor prognosis
83.	Donnino, 2007 [98]	79	Retrospective	–	6 h, 12 h	12 h	Decrease in lactate independent predictor of hospital survival
84.	Arnalich, 2010 [99]	85	Prospective	–	6 h	6 h	Decrease in lactate significantly higher in 24-h survivors compared with nonsurvivors
85.	Le Guen, 2011 [100]	51	Prospective	–	1 h	1 h	Decrease in blood lactate >10 % significantly different in survivors and nonsurvivors treated with ECMO
86.	Starodub, 2013 [101]	199	Retrospective	–	6 h, 12 h, 24 h	12 h, 24 h	Change in lactate over time not predictive of survival but lower mean lactate levels at 12 and 24 h associated with increased survival
87.	Donnino, 2014 [102]	100	Prospective	–	12 h, 24 h	12 h	Greater percentage decrease independently associated with survival
88.	Riveiro, 2015 [103]	54	Prospective	–	6 h, 12 h, 24 h, 48 h, 72 h	6 h	Decrease in lactate predictive of 28-day survival
89.	Williams, 2016 [104]	167	Retrospective	–	Variable	4 h	More rapid decrease in lactate in survivors
	Respiratory failure
90.	Zhao, 2010 [105]	110	Prospective	–	6 h	6 h	Lactate decrease ≥10 % associated with improved survival
91.	Wu, 2012 [106]	27	Prospective	–	12 h, 24 h, 48 h, 72 h	12 h, 24 h, 48 h, 72 h	Smaller decrease in lactate predictive of outcome
92.	Zang, 2014 [107]	43	Prospective	–	6 h	6 h	Decrease in lactate independent predictor of survival in patients treated by ECMO
	Others
93.	Scott, 2010 [110]	95	Prospective	–	1 h, 2 h, 6 h, 24 h	2 h	Lactate decrease <15 % predictive of poor outcome (hospital mortality or endotracheal intubation) in patients with cardiorespiratory insufficiency
94.	Wu, 2011 [109]	222	Prospective	–	6 h	6 h	Lactate decrease of <24.8 % at 6 h associated with higher incidence of liver graft failure and mortality
95.	Lui, 2013 [108]	204	Prospective	≥2	12 h	12 h	Smaller decrease in lactate associated with increased mortality in patients with paraquat poisoning
96.	Mohamed, 2014 [111]	46	Prospective	–	8 h, 24 h	24 h	Mortality greater if <40 % decrease in lactate

EMCO extracorporeal membrane oxygenation, ER emergency room, h hours, NR not reported, ScvO ₂ central venous oxygen saturation

General ICU patients

Observational studies

We identified 13 observational studies in heterogeneous critically ill populations [6, 10‐12, 23‐31]. All of these studies indicated that nonsurvivors had persistently higher lactate concentrations over time than survivors. Only one study [26] reported that lactate reduction during the first 24 hrs of ICU stay was useful only in septic patients, but not in patients with hemorrhage or other conditions.

The suggested optimal timing of lactate measurements was not precisely defined in several of the studies that evaluated the course of lactate concentrations over time. The studies that did include a time interval usually selected 6, 12 or even 24 hrs.

Interventional studies

An interventional trial of 348 patients by Jansen et al. [15] targeted a lactate decrease of at least 20 % in 2 hrs for the initial 8 hrs of treatment in ICU patients with an initial lactate ≥ 3 mEq/l. This strategy was associated with a lower mortality rate in the lactate-guided therapy group after adjustment for predefined risk factors (hazard ratio (HR), 0.61; confidence interval (CI), 0.43–0.87).

Surgical patients

We identified five observational studies conducted in general surgical ICU patients [32‐36]. Failure of lactate concentrations to decrease over time was associated with worse outcomes in all studies.

After cardiac surgery

There were five observational studies in cardiac surgery patients [37‐41], including two studies in patients treated with extracorporeal membrane oxygenation (ECMO) post cardiac surgery [39, 41]. All studies consistently demonstrated differences in changes in lactate concentration between survivors and nonsurvivors.

Trauma patients

Observational studies

We identified twelve observational studies in trauma patients [42‐53]. Three retrospective studies reported no association of change in lactate levels with mortality [43, 47, 52], although Manikis et al. [43] reported that the duration of hyperlactatemia was associated with the development of organ failure and Billeter et al. [47] noted that delayed or no reduction in blood lactate was associated with increased infectious complications. Several small studies used relatively long time intervals of 12–24 hrs [45, 54]. One study reported that repeated lactate after 2 hrs could be valuable [48] and a retrospective study proposed a time limit of 6 hrs [50].

Interventional studies

In a retrospective analysis of a small prospective cohort managed according to a protocol to normalize blood lactate levels, Blow et al. [55] reported that failure to normalize blood lactate levels (<2.5 mmol/l) was associated with increased morbidity and mortality. In an interventional study by Claridge et al. [56], patients were managed according to the same protocol targeted at reducing lactate levels to <2.4 mmol/l. Failure to achieve this target was associated with increased risk of infection, increased length of stay, and increased mortality.

Patients with sepsis

Observational studies

We found thirty four observational studies in patients with sepsis [17, 18, 57‐88]. One study reported that a decrease in lactate levels of ≥10 % was not associated with mortality [88], but this study was conducted in a low-resource setting, such that resuscitation may not have been optimal as acknowledged by the authors. Several studies reported that 6-hrly changes could be a useful guide [63, 64, 66, 67, 69‐72, 78].

Interventional studies

One interventional study by Jones et al. [16] compared resuscitation based on lactate concentrations with a target of obtaining a >10 % decrease from the initial value with resuscitation based on achieving central venous oxygen saturation (ScvO₂) ≥ 70 %; there were no differences in outcome between the two strategies. In an analysis of patients in this trial who had simultaneous lactate and ScvO₂ measurements, Puskarich et al. [69] concluded that failure to achieve the target lactate decrease was associated with a worse prognosis than failure to achieve the ScvO₂ target. In a small Chinese study [89], patients randomized to a 30 % decrease in lactate target had better 28-day survival than those randomized to a 10 % target or to control, and in another small study [90] there were no differences in in-hospital mortality using management targeted at a 10 % decrease in lactate compared with management to normalize ScvO₂. Two other Chinese studies reported that patients randomized to lactate-directed therapy had improved outcomes [91, 92].

Patients with cardiogenic shock

There were four studies in patients with cardiogenic shock [93‐96], all showing that lactate concentrations decreased more in survivors than in nonsurvivors.

After cardiac arrest

We identified eight observational studies [97‐104] in post-cardiac arrest patients. All but one [101] of these studies demonstrated differences in changes in lactate concentration between survivors and nonsurvivors.

Patients with acute respiratory failure

We found three observational studies in patients with acute respiratory failure [105‐107], all showing that decreasing lactate levels were predictive of survival.

Other conditions

Changes in lactate concentrations were also reported following paraquat poisoning [108], after liver transplantation [109], in patients with acute cardiorespiratory failure [110], and in patients with severe community-acquired pneumonia [111]. All studies indicated the value of repeated lactate concentrations in these patient populations.

Discussion

Our literature review clearly supports the value of serial lactate measurements in the evaluation of critically ill patients and their response to therapy. This observation was similar across all studies and in all categories of patients, without being restricted to those with sepsis. We found only one study which suggested that evaluating the time course of lactate concentrations would be useful in sepsis patients but not in other conditions [26], and just five studies reporting no predictive effect of decrease in lactate levels over time on mortality [43, 47, 52, 88, 101] although two of these did suggest a relationship with morbidity outcomes [43, 47]. Repeated lactate concentrations can also help separate patients with complications, such as neurological complications after cardiac arrest [112, 113] or after surgery [38]. A meta-analysis of these data is complicated by the heterogeneity of the populations and the different timings of the measurements, but the data are very consistent across studies.

Increased lactate concentrations can be due to factors other than cellular hypoxia, so the decrease in blood lactate concentrations may not just be the result of improvements in cellular oxygen availability. For example, beta-adrenergic stimulation may contribute to increased lactate production [114]. A recent study indicated the reverse phenomenon; that is, the increase in lactate concentrations seen in patients with sepsis may be blunted in patients previously treated with beta-blocking agents [115]. The infusion of lactate-containing intravenous solutions may also potentially complicate the interpretation of blood lactate concentrations [116], although the amount of fluid infused must be very large to have such an effect [117]. A recent study also reported that lactate levels decrease more slowly in patients with a positive blood alcohol level, thus complicating evaluation of blood lactate levels in these patients [118].

Because lactate is primarily metabolized in the liver, liver dysfunction may alter lactate clearance. Thus, some studies have questioned whether blood lactate concentrations can be used to indicate tissue hypoperfusion in critically ill patients with hepatic dysfunction. However, patients with stable cirrhosis have normal lactate concentrations [8]. Kruse et al. [119] analyzed the incidence of hyperlactatemia in patients with liver disease and showed that lactic acidosis was associated with clinical evidence of shock and increased hospital mortality. Chiolero et al. [120] reported that major hepatectomy was not associated with any global changes in lactate clearance, although lactate half-life was prolonged. A recent experimental study indicated that liver hypoperfusion is unlikely to contribute to increased blood lactate concentrations [121]. In patients with paracetamol-induced acute liver failure, higher lactate concentrations were associated with more severe organ failure and mortality [122].

Some investigators have compared lactate and ScvO₂ or combined the two measures. Lactate is usually a better prognostic marker [69]. But is it actually necessary to choose? In an interventional study in patients with sepsis, Jones et al. [16] reported no differences in outcomes for patients managed according to lactate concentrations or to ScvO₂ values, but it is difficult to evaluate how these measurements really guided therapy because there were no differences in administered treatments during the first 72 hrs. In post-cardiac surgery patients, Polonen et al. [14] reported better outcomes when ScvO₂ and lactate concentrations were targeted together than in control patients. The most convincing evidence in favor of lactate as a target comes from the study by Jansen et al. [15] in which outcomes were improved in patients treated to a target of a 20 % decrease in lactate concentrations. Nevertheless, the relatively slow changes in lactate make it difficult to interpret these results—the trend analysis is more a marker of effective treatment than a target in itself.

Although changes in blood lactate kinetics were clearly significant after 6 hrs in many studies and after 12 hrs in most, it is currently not possible to define the best time interval between lactate measurements. The normal reduction in lactate concentrations when overproduction of lactate abruptly ceases after grand mal seizures is about 50 % in 1 hr [13]. Although Levraut et al. [21] suggested that lactate clearance may be decreased in septic patients, Revelly et al. [22] reported similar values in patients with sepsis and in healthy volunteers.

The rate of lactate decrease in optimal treatment conditions is quite variable. In the best conditions, blood lactate concentrations decreased by more than 10 % in 1 hr in patients who responded rapidly to resuscitation [12] or by 10–20 % in 2 hrs [15]. A study by Hernandez et al. [123] suggested a >50 % decrease in lactate concentrations during the first 6 hrs of resuscitation in patients with septic shock. Although some systems now allow the quasi-continuous measurement of lactate concentrations, determinations every 1–2 hrs are probably sufficient; in the interventional study by Jansen et al. [15] the protocol was to measure blood lactate every 2 hrs. Even though serial blood lactate concentrations have been suggested to guide therapy, our review underlines that changes in lactate over time are relatively slow, taking place over hrs, and this may be too slow to guide therapy. Serial lactate concentrations should serve as a regular control, similar to how in the past a navigator would consult a compass from time to time to ensure that their boat was still heading in the right direction. If lactate concentrations do not normalize over time, the need for changes in therapy should be considered.

Conclusion

Our systematic literature review has provided the following answers to our initial questions. First, observation of a better prognosis with decreasing lactate concentrations is consistent throughout the literature. Second, these observations are not specific to septic patients, but apply to all common situations of hyperlactatemia and in heterogeneous patient populations. Third, the changes are relatively slow, and it is difficult to provide recommendations about the speed of decrease in lactate concentrations in the best conditions. Clearly repeating measurements every 12 hrs can generally separate those who will do well from those who are likely to die, but shorter time intervals may be helpful. On the basis of our observations, we would recommend checking blood lactate concentrations as often as every 1–2 hrs in acute conditions. Fourth, the study of lactate kinetics appears to be valid regardless of the initial value and not only in patients with severe hyperlactatemia.

Abbreviations

ECMO, extracorporeal membrane oxygenation; ScvO₂, central venous oxygen saturation

Acknowledgements

None.

Funding

Institutional funds only.

Availability of supporting data

Not applicable.

Authors’ contributions

AQeS and LC performed the literature search and drafted the manuscript. J-LV and FST reviewed the article for critical content. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Not applicable.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Broder G, Weil MH. Excess lactate: an index of reversibility of shock in human patients. Science. 1964;143:1457–9.PubMedCrossRef

Weil MH, Afifi AA. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation. 1970;41:989–1001.PubMedCrossRef

Peretz DI, McGregor M, Dossetor JB. Lactic acidosis: a clinically significant aspect of shock. Can Med Assoc J. 1964;90:673–5.PubMedPubMedCentral

Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369:1726–34.PubMedCrossRef

Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care. 2006;12:315–21.PubMedCrossRef

Nichol AD, Egi M, Pettila V, Bellomo R, French C, Hart G, et al. Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study. Crit Care. 2010;14:R25.PubMedPubMedCentralCrossRef

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801–10.PubMedPubMedCentralCrossRef

Kraut JA, Madias NE. Lactic acidosis. N Engl J Med. 2014;371:2309–19.PubMedCrossRef

Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40:1795–815.PubMedPubMedCentralCrossRef

10.

Nichol A, Bailey M, Egi M, Pettila V, French C, Stachowski E, et al. Dynamic lactate indices as predictors of outcome in critically ill patients. Crit Care. 2011;15:R242.PubMedPubMedCentralCrossRef

11.

Haas SA, Lange T, Saugel B, Petzoldt M, Fuhrmann V, Metschke M, et al. Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patients. Intensive Care Med. 2016;42:202–10.PubMedCrossRef

12.

Vincent JL, Dufaye P, Berre J, Leeman M, Degaute JP, Kahn RJ. Serial lactate determinations during circulatory shock. Crit Care Med. 1983;11:449–51.PubMedCrossRef

13.

Orringer CE, Eustace JC, Wunsch CD, Gardner LB. Natural history of lactic acidosis after grand-mal seizures. A model for the study of an anion-gap acidosis not associated with hyperkalemia. N Engl J Med. 1977;297:796–9.PubMedCrossRef

14.

Polonen P, Ruokonen E, Hippelainen M, Poyhonen M, Takala J. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg. 2000;90:1052–9.PubMedCrossRef

15.

Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, Lima AP, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182:752–61.PubMedCrossRef

16.

Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303:739–46.PubMedPubMedCentralCrossRef

17.

Dettmer M, Holthaus CV, Fuller BM. The impact of serial lactate monitoring on emergency department resuscitation interventions and clinical outcomes in severe sepsis and septic shock: an observational cohort study. Shock. 2015;43:55–61.PubMedPubMedCentralCrossRef

18.

Nguyen HB, Kuan WS, Batech M, Shrikhande P, Mahadevan M, Li CH, et al. Outcome effectiveness of the severe sepsis resuscitation bundle with addition of lactate clearance as a bundle item: a multi-national evaluation. Crit Care. 2011;15:R229.PubMedPubMedCentralCrossRef

19.

Vincent JL. Serial blood lactate levels reflect both lactate production and clearance. Crit Care Med. 2015;43:e209.PubMedCrossRef

20.

Vincent JL. Lactic acidosis. N Engl J Med. 2015;372:1077–8.PubMed

21.

Levraut J, Ciebiera JP, Chave S, Rabary O, Jambou P, Carles M, et al. Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med. 1998;157:1021–6.PubMedCrossRef

22.

Revelly JP, Tappy L, Martinez A, Bollmann M, Cayeux MC, Berger MM, et al. Lactate and glucose metabolism in severe sepsis and cardiogenic shock. Crit Care Med. 2005;33:2235–40.PubMedCrossRef

23.

Cowan BN, Burns HJ, Boyle P, Ledingham IM. The relative prognostic value of lactate and haemodynamic measurements in early shock. Anaesthesia. 1984;39:750–5.PubMedCrossRef

24.

Suistomaa M, Ruokonen E, Kari A, Takala J. Time-pattern of lactate and lactate to pyruvate ratio in the first 24 hrs of intensive care emergency admissions. Shock. 2000;14:8–12.PubMedCrossRef

25.

Wang H, Wu DW, Chen XM, Li C, Ding SF, Zhai Q, et al. Relationship between blood lactic level, lactic clearance, duration of lacticemia and prognosis of critically ill patients in intensive care unit. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009;21:357–60.PubMed

26.

Jansen TC, van Bommel J, Mulder PG, Lima AP, van der Hoven B, Rommes JH, et al. Prognostic value of blood lactate levels: does the clinical diagnosis at admission matter? J Trauma. 2009;66:377–85.PubMedCrossRef

27.

Krishna U, Joshi SP, Modh M. An evaluation of serial blood lactate measurement as an early predictor of shock and its outcome in patients of trauma or sepsis. Indian J Crit Care Med. 2009;13:66–73.PubMedPubMedCentralCrossRef

28.

Soliman HM, Vincent JL. Prognostic value of admission serum lactate concentrations in intensive care unit patients. Acta Clin Belg. 2010;65:176–81.PubMedCrossRef

29.

van Beest PA, Brander L, Jansen SP, Rommes JH, Kuiper MA, Spronk PE. Cumulative lactate and hospital mortality in ICU patients. Ann Intensive Care. 2013;3:6.PubMedPubMedCentralCrossRef

30.

Zhang Z, Chen K, Ni H, Fan H. Predictive value of lactate in unselected critically ill patients: an analysis using fractional polynomials. J Thorac Dis. 2014;6:995–1003.PubMedPubMedCentral

31.

Jansen TC, van Bommel J, Mulder PG, Rommes JH, Schieveld SJ, Bakker J. The prognostic value of blood lactate levels relative to that of vital signs in the pre-hospital setting: a pilot study. Crit Care. 2008;12:R160.PubMedPubMedCentralCrossRef

32.

McNelis J, Marini CP, Jurkiewicz A, Szomstein S, Simms HH, Ritter G, et al. Prolonged lactate clearance is associated with increased mortality in the surgical intensive care unit. Am J Surg. 2001;182:481–5.PubMedCrossRef

33.

Husain FA, Martin MJ, Mullenix PS, Steele SR, Elliott DC. Serum lactate and base deficit as predictors of mortality and morbidity. Am J Surg. 2003;185:485–91.PubMedCrossRef

34.

Meregalli A, Oliveira RP, Friedman G. Occult hypoperfusion is associated with increased mortality in hemodynamically stable, high-risk, surgical patients. Crit Care. 2004;8:R60–5.PubMedPubMedCentralCrossRef

35.

Cardinal Fernandez PA, Olano E, Acosta C, Bertullo H, Albornoz H, Bagnulo H. Prognostic value of lactate clearance in the first 6 hrs of intensive medicine course. Med Intensiva. 2009;33:166–70.PubMedCrossRef

36.

Ibrahim WA, Ahmed AS. Serial estimations of blood lactate predict postoperative outcome in cancer patients undergoing head and neck surgeries. Egyptian J Anaesth. 2013;29:149–54.CrossRef

37.

Lindsay AJ, Xu M, Sessler DI, Blackstone EH, Bashr CA. Lactate clearance time and concentration linked to morbidity and death in cardiac surgical patients. Ann Thorac Surg. 2013;95:486–92.PubMedCrossRef

38.

Hajjar LA, Almeida JP, Fukushima JT, Rhodes A, Vincent JL, Osawa EA, et al. High lactate levels are predictors of major complications after cardiac surgery. J Thorac Cardiovasc Surg. 2013;146:455–60.PubMedCrossRef

39.

Park SJ, Kim SP, Kim JB, Jung SH, Choo SJ, Chung CH, et al. Blood lactate level during extracorporeal life support as a surrogate marker for survival. J Thorac Cardiovasc Surg. 2014;148:714–20.PubMedCrossRef

40.

Lopez-Delgado JC, Esteve F, Javierre C, Torrado H, Rodriguez-Castro D, Carrio ML, et al. Evaluation of serial arterial lactate levels as a predictor of hospital and long-term mortality in patients after cardiac surgery. J Cardiothorac Vasc Anesth. 2015;29:1441–53.PubMedCrossRef

41.

Li CL, Wang H, Jia M, Ma N, Meng X, Hou XT. The early dynamic behavior of lactate is linked to mortality in postcardiotomy patients with extracorporeal membrane oxygenation support: A retrospective observational study. J Thorac Cardiovasc Surg. 2015;149:1445–50.PubMedCrossRef

42.

Abramson D, Scalea TM, Hitchcock R, Trooskin SZ, Henry SM, Greenspan J. Lactate clearance and survival following injury. J Trauma. 1993;35:584–8.PubMedCrossRef

43.

Manikis P, Jankowski S, Zhang H, Kahn RJ, Vincent JL. Correlation of serial blood lactate levels to organ failure and mortality after trauma. Am J Emerg Med. 1995;13:619–22.PubMedCrossRef

44.

Holm C, Melcer B, Horbrand F, Worl HH, von Donnersmarck GH, Muhlbauer W. Haemodynamic and oxygen transport responses in survivors and non-survivors following thermal injury. Burns. 2000;26:25–33.PubMedCrossRef

45.

Cerovic O, Golubovic V, Spec-Marn A, Kremzar B, Vidmar G. Relationship between injury severity and lactate levels in severely injured patients. Intensive Care Med. 2003;29:1300–5.PubMedCrossRef

46.

Kamolz LP, Andel H, Schramm W, Meissl G, Herndon DN, Frey M. Lactate: early predictor of morbidity and mortality in patients with severe burns. Burns. 2005;31:986–90.PubMedCrossRef

47.

Billeter A, Turina M, Seifert B, Mica L, Stocker R, Keel M. Early serum procalcitonin, interleukin-6, and 24-hr lactate clearance: useful indicators of septic infections in severely traumatized patients. World J Surg. 2009;33:558–66.PubMedCrossRef

48.

Regnier MA, Raux M, Le MY, Asencio Y, Gaillard J, Devilliers C, et al. Prognostic significance of blood lactate and lactate clearance in trauma patients. Anesthesiology. 2012;117:1276–88.PubMedCrossRef

49.

Dubendorfer C, Billeter AT, Seifert B, Keel M, Turina M. Serial lactate and admission SOFA scores in trauma: an analysis of predictive value in 724 patients with and without traumatic brain injury. Eur J Trauma Emerg Surg. 2013;39:25–34.PubMedCrossRef

50.

Odom SR, Howell MD, Silva GS, Nielsen VM, Gupta A, Shapiro NI, et al. Lactate clearance as a predictor of mortality in trauma patients. J Trauma Acute Care Surg. 2013;74:999–1004.PubMedCrossRef

51.

Heinonen E, Hardcastle TC, Barle H, Muckart DJ. Lactate clearance predicts outcome after major trauma. Afr J Emerg Med. 2014;4:61–5.CrossRef

52.

Freitas AD, Franzon O. Lactate as predictor of mortality in polytrauma. Arq Bras Cir Dig. 2015;28:163–6.PubMedPubMedCentralCrossRef

53.

Dezman ZD, Comer AC, Smith GS, Narayan M, Scalea TM, Hirshon JM. Failure to clear elevated lactate predicts 24-hr mortality in trauma patients. J Trauma Acute Care Surg. 2015;79:580–5.PubMedCrossRef

54.

Roumen RM, Redl H, Schlag G, Sandtner W, Koller W, Goris RJ. Scoring systems and blood lactate concentrations in relation to the development of adult respiratory distress syndrome and multiple organ failure in severely traumatized patients. J Trauma. 1993;35:349–55.PubMedCrossRef

55.

Blow O, Magliore L, Claridge JA, Butler K, Young JS. The golden hr and the silver day: detection and correction of occult hypoperfusion within 24 hrs improves outcome from major trauma. J Trauma. 1999;47:964–9.PubMedCrossRef

56.

Claridge JA, Crabtree TD, Pelletier SJ, Butler K, Sawyer RG, Young JS. Persistent occult hypoperfusion is associated with a significant increase in infection rate and mortality in major trauma patients. J Trauma. 2000;48:8–14.PubMedCrossRef

57.

Bakker J, Coffernils M, Leon M, Gris P, Vincent JL. Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest. 1991;99:956–62.PubMedCrossRef

58.

Friedman G, Berlot G, Kahn RJ, Vincent JL. Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis. Crit Care Med. 1995;23:1184–93.PubMedCrossRef

59.

Bernardin G, Pradier C, Tiger F, Deloffre P, Mattei M. Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock. Intensive Care Med. 1996;22:17–25.PubMedCrossRef

60.

Marecaux G, Pinsky MR, Dupont E, Kahn RJ, Vincent JL. Blood lactate levels are better prognostic indicators than TNF and IL-6 levels in patients with septic shock. Intensive Care Med. 1996;22:404–8.PubMedCrossRef

61.

Bakker J, Gris P, Coffernils M, Kahn RJ, Vincent JL. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg. 1996;171:221–6.PubMedCrossRef

62.

Kobayashi S, Gando S, Morimoto Y, Nanzaki S, Kemmotsu O. Serial measurement of arterial lactate concentrations as a prognostic indicator in relation to the incidence of disseminated intravascular coagulation in patients with systemic inflammatory response syndrome. Surg Today. 2001;31:853–9.PubMedCrossRef

63.

Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32:1637–42.PubMedCrossRef

64.

Nguyen HB, Corbett SW, Steele R, Banta J, Clark RT, Hayes SR, et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med. 2007;35:1105–12.PubMedCrossRef

65.

Phua J, Koay ES, Lee KH. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock. 2008;29:328–33.PubMedCrossRef

66.

Yang CS, Qiu HB, Huang YZ, Xie JF, Mo M, Liu SQ, et al. Prospective research on the prognosis of septic shock based on the change of lactate concentration in arterial blood. Zhonghua Wai Ke Za Zhi. 2009;47:685–8.PubMed

67.

Arnold RC, Shapiro NI, Jones AE, Schorr C, Pope J, Casner E, et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock. 2009;32:35–9.PubMedCrossRef

68.

Nguyen HB, Loomba M, Yang JJ, Jacobsen G, Shah K, Otero RM, et al. Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock. J Inflamm (Lond). 2010;7:6.CrossRef

69.

Puskarich MA, Trzeciak S, Shapiro NI, Arnold RC, Heffner AC, Kline JA, et al. Prognostic value and agreement of achieving lactate clearance or central venous oxygen saturation goals during early sepsis resuscitation. Acad Emerg Med. 2012;19:252–8.PubMedPubMedCentralCrossRef

70.

Zanaty OM, Megahed M, Demerdash H, Swelem R. Delta neutrophil index versus lactate clearance: early markers for outcome prediction in septic shock patients. Alex J Med. 2012;48:327–33.CrossRef

71.

Puskarich MA, Trzeciak S, Shapiro NI, Albers AB, Heffner AC, Kline JA, et al. Whole blood lactate kinetics in patients undergoing quantitative resuscitation for severe sepsis and septic shock. Chest. 2013;143:1548–53.PubMedCrossRef

72.

Walker CA, Griffith DM, Gray AJ, Datta D, Hay AW. Early lactate clearance in septic patients with elevated lactate levels admitted from the emergency department to intensive care: time to aim higher? J Crit Care. 2013;28:832–7.PubMedCrossRef

73.

Liu V, Morehouse JW, Soule J, Whippy A, Escobar GJ. Fluid volume, lactate values, and mortality in sepsis patients with intermediate lactate values. Ann Am Thorac Soc. 2013;10:466–73.PubMedCrossRef

74.

Marty P, Roquilly A, Vallee F, Luzi A, Ferre F, Fourcade O, et al. Lactate clearance for death prediction in severe sepsis or septic shock patients during the first 24 hrs in intensive care unit: an observational study. Ann Intensive Care. 2013;3:3.PubMedPubMedCentralCrossRef

75.

Park JH, Lee J, Park YS, Lee CH, Lee SM, Yim JJ, et al. Prognostic value of central venous oxygen saturation and blood lactate levels measured simultaneously in the same patients with severe systemic inflammatory response syndrome and severe sepsis. Lung. 2014;192:435–40.PubMedCrossRef

76.

Permpikul C, Sringam P, Tongyoo S. Therapeutic goal achievements during severe sepsis and septic shock resuscitation and their association with patients' outcomes. J Med Assoc Thai. 2014;97 Suppl 3:S176–83.PubMed

77.

Bao L, Zhang M, Yan P, Wu X, Shao J, Zheng R. Retrospective analysis of the value of arterial blood lactate level and its clearance rate on the prognosis of septic shock patients. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015;27:38–42.PubMed

78.

Galbois A, Bige N, Pichereau C, Boelle PY, Baudel JL, Bourcier S, et al. Exploration of skin perfusion in cirrhotic patients with septic shock. J Hepatol. 2015;62:549–55.PubMedCrossRef

79.

Lee SM, Kim SE, Kim EB, Jeong HJ, Son YK, An WS. Lactate clearance and vasopressor seem to be predictors for mortality in severe sepsis patients with lactic acidosis supplementing sodium bicarbonate: a retrospective analysis. PLoS One. 2015;10:e0145181.PubMedPubMedCentralCrossRef

80.

Lokhandwala S, Moskowitz A, Lawniczak R, Giberson T, Cocchi MN, Donnino MW. Disease heterogeneity and risk stratification in sepsis-related occult hypoperfusion: a retrospective cohort study. J Crit Care. 2015;30:531–6.PubMedPubMedCentralCrossRef

81.

Wang H, Li Z, Yin M, Chen XM, Ding SF, Li C, et al. Combination of Acute Physiology and Chronic Health Evaluation II score, early lactate area, and N-terminal prohormone of brain natriuretic peptide levels as a predictor of mortality in geriatric patients with septic shock. J Crit Care. 2015;30:304–9.PubMedCrossRef

82.

Bhat SR, Swenson KE, Francis MW, Wira CR. Lactate clearance predicts survival among patients in the emergency department with severe sepsis. West J Emerg Med. 2015;16:1118–26.PubMedPubMedCentralCrossRef

83.

Chertoff J, Chisum M, Simmons L, King B, Walker M, Lascano J. Prognostic utility of plasma lactate measured between 24 and 48 h after initiation of early goal-directed therapy in the management of sepsis, severe sepsis, and septic shock. J Intensive Care. 2016;4:13.PubMedPubMedCentralCrossRef

84.

Drumheller BC, Agarwal A, Mikkelsen ME, Sante SC, Weber AL, Goyal M, et al. Risk factors for mortality despite early protocolized resuscitation for severe sepsis and septic shock in the emergency department. J Crit Care. 2016;31:13–20.PubMedCrossRef

85.

He HW, Liu DW, Long Y, Wang XT. High central venous-to-arterial CO2 difference/arterial-central venous O2 difference ratio is associated with poor lactate clearance in septic patients after resuscitation. J Crit Care. 2016;31:76–81.PubMedCrossRef

86.

Ha TS, Shin TG, Jo IJ, Hwang SY, Chung CR, Suh GY et al. Lactate clearance and mortality in septic patients with hepatic dysfunction. Am J Emerg Med. 2016;34:1011–15.

87.

Bolvardi E, Malmir J, Reihani H, Hashemian AM, Bahramian M, Khademhosseini P, et al. The role of lactate clearance as a predictor of organ dysfunction and mortality in patients with severe sepsis. Mater Sociomed. 2016;28:57–60.PubMedPubMedCentralCrossRef

88.

Amir A, Saulters KJ, Olum S, Pitts K, Parsons A, Churchill C et al. Outcomes of patients with severe sepsis after the first 6 hrs of resuscitation at a regional referral hospital in Uganda. J Crit Care. 2016;33:78–83.

89.

Tian HH, Han SS, Lv CJ, Wang T, Li Z, Hao D, et al. The effect of early goal lactate clearance rate on the outcome of septic shock patients with severe pneumonia. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012;24:42–5.PubMed

90.

Yu B, Tian HY, Hu ZJ, Zhao C, Liu LX, Zhang Y, et al. Comparison of the effect of fluid resuscitation as guided either by lactate clearance rate or by central venous oxygen saturation in patients with sepsis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013;25:578–83.PubMed

91.

Lyu X, Xu Q, Cai G, Yan J, Yan M. Efficacies of fluid resuscitation as guided by lactate clearance rate and central venous oxygen saturation in patients with septic shock. Zhonghua Yi Xue Za Zhi. 2015;95:496–500.PubMed

92.

Kuan WS, Ibrahim I, Leong BS, Jain S, Lu Q, Cheung YB, et al. Emergency department management of sepsis patients: a randomized, goal-oriented, noninvasive sepsis trial. Ann Emerg Med. 2016;67:367–78.PubMedCrossRef

93.

Attana P, Lazzeri C, Chiostri M, Picariello C, Gensini GF, Valente S. Lactate clearance in cardiogenic shock following ST elevation myocardial infarction: a pilot study. Acute Card Care. 2012;14:20–6.PubMedCrossRef

94.

Attana P, Lazzeri C, Chiostri M, Picariello C, Gensini GF, Valente S. Strong-ion gap approach in patients with cardiogenic shock following ST-elevation myocardial infarction. Acute Card Care. 2013;15:58–62.PubMedCrossRef

95.

Park TK, Yang JH, Choi SH, Song YB, Hahn JY, Choi JH, et al. Clinical outcomes of patients with acute myocardial infarction complicated by severe refractory cardiogenic shock assisted with percutaneous cardiopulmonary support. Yonsei Med J. 2014;55:920–7.PubMedPubMedCentralCrossRef

96.

Guenther S, Theiss HD, Fischer M, Sattler S, Peterss S, Born F, et al. Percutaneous extracorporeal life support for patients in therapy refractory cardiogenic shock: initial results of an interdisciplinary team. Interact Cardiovasc Thorac Surg. 2014;18:283–91.PubMedCrossRef

97.

Kliegel A, Losert H, Sterz F, Holzer M, Zeiner A, Havel C, et al. Serial lactate determinations for prediction of outcome after cardiac arrest. Medicine (Baltimore). 2004;83:274–9.CrossRef

98.

Donnino MW, Miller J, Goyal N, Loomba M, Sankey SS, Dolcourt B, et al. Effective lactate clearance is associated with improved outcome in post-cardiac arrest patients. Resuscitation. 2007;75:229–34.PubMedCrossRef

99.

Arnalich F, Menendez M, Lagos V, Ciria E, Quesada A, Codoceo R, et al. Prognostic value of cell-free plasma DNA in patients with cardiac arrest outside the hospital: an observational cohort study. Crit Care. 2010;14:R47.PubMedPubMedCentralCrossRef

100.

Le Guen M, Nicolas-Robin A, Carreira S, Raux M, Leprince P, Riou B, et al. Extracorporeal life support following out-of-hospital refractory cardiac arrest. Crit Care. 2011;15:R29.PubMedPubMedCentralCrossRef

101.

Starodub R, Abella BS, Grossestreuer AV, Shofer FS, Perman SM, Leary M, et al. Association of serum lactate and survival outcomes in patients undergoing therapeutic hypothermia after cardiac arrest. Resuscitation. 2013;84:1078–82.PubMedCrossRef

102.

Donnino MW, Andersen LW, Giberson T, Gaieski DF, Abella BS, Peberdy MA, et al. Initial lactate and lactate change in post-cardiac arrest: a multicenter validation study. Crit Care Med. 2014;42:1804–11.PubMedPubMedCentralCrossRef

103.

Riveiro DF, de Oliveira VM, Braunner JS, Vieira SR. Evaluation of serum lactate, central venous saturation, and venous-arterial carbon dioxide difference in the prediction of mortality in postcardiac arrest syndrome. J Intensive Care Med. 2015. [Epub ahead of print]

104.

Williams TA, Martin R, Celenza A, Bremner A, Fatovich D, Krause J, et al. Use of serum lactate levels to predict survival for patients with out-of-hospital cardiac arrest: a cohort study. Emerg Med Australas. 2016;28:171–8.PubMedCrossRef

105.

Zhao YF, Lin Y, Zhu XL. Clinical significance of early lactate clearance rate in patients with respiratory failure. Zhonghua Jie He He Hu Xi Za Zhi. 2010;33:183–7.PubMed

106.

Wu WH, Niu YY, Zhang CR, Xiao LB, Ye HS, Pan DM, et al. Combined APACH II score and arterial blood lactate clearance rate to predict the prognosis of ARDS patients. Asian Pac J Trop Med. 2012;5:656–60.PubMedCrossRef

107.

Zang Z, Xu H, Dong L, Gao F, Yan J. Prognostic significance of early lactate clearance rate for severe acute respiratory failure patients on extracorporeal membrane oxygenation. Zhonghua Jie He He Hu Xi Za Zhi. 2014;37:197–201.PubMed

108.

Liu XW, Ma T, Qu B, Ji Y, Liu Z. Prognostic value of initial arterial lactate level and lactate metabolic clearance rate in patients with acute paraquat poisoning. Am J Emerg Med. 2013;31:1230–5.PubMedCrossRef

109.

Wu JF, Wu RY, Chen J, Ou-Yang B, Chen MY, Guan XD. Early lactate clearance as a reliable predictor of initial poor graft function after orthotopic liver transplantation. Hepatobiliary Pancreat Dis Int. 2011;10:587–92.PubMedCrossRef

110.

Scott S, Antonaglia V, Guiotto G, Paladino F, Schiraldi F. Two-hr lactate clearance predicts negative outcome in patients with cardiorespiratory insufficiency. Crit Care Res Pract. 2010;2010:917053.PubMedPubMedCentral

111.

Mohamed KAE, Ahmed DAE. Prognostic value of lactate clearance in severe community-acquired pneumonia. Egypt J Chest Dis Tuberc. 2014;63:1053–8.CrossRef

112.

Lee TR, Kang MJ, Cha WC, Shin TG, Sim MS, Jo IJ, et al. Better lactate clearance associated with good neurologic outcome in survivors who treated with therapeutic hypothermia after out-of-hospital cardiac arrest. Crit Care. 2013;17:R260.PubMedPubMedCentralCrossRef

113.

Matsumoto H, Nihei S, Endo T, Kanazawa A, Arai H, Nagata K, et al. Examination of relationship between lactate clearance and neurologic outcome in cardiac arrest induced by ventricular fibrillation. J UOEH. 2014;36:11–6.PubMedCrossRef

114.

Qvisth V, Hagstrom-Toft E, Enoksson S, Bolinder J. Catecholamine regulation of local lactate production in vivo in skeletal muscle and adipose tissue: role of -adrenoreceptor subtypes. J Clin Endocrinol Metab. 2008;93:240–6.PubMedCrossRef

115.

Contenti J, Occelli C, Corraze H, Lemoel F, Levraut J. Long-term beta-blocker therapy decreases blood lactate concentration in severely septic patients. Crit Care Med. 2015;43:2616–22.PubMedCrossRef

116.

Orbegozo Cortes D, Rayo Bonor A, Vincent JL. Isotonic crystalloid solutions: a structured review of the literature. Br J Anaesth. 2014;112:968–81.PubMedCrossRef

117.

Didwania A, Miller J, Kassel D, Jackson Jr EV, Chernow B. Effect of intravenous lactated Ringer's solution infusion on the circulating lactate concentration: Part 3. Results of a prospective, randomized, double-blind, placebo-controlled trial. Crit Care Med. 1997;25:1851–4.PubMedCrossRef

118.

Dezman ZD, Comer AC, Narayan M, Scalea TM, Hirshon JM, Smith GS. Alcohol consumption decreases lactate clearance in acutely injured patients. Injury. 2016. [Epub ahead of print]

119.

Kruse JA, Zaidi SA, Carlson RW. Significance of blood lactate levels in critically ill patients with liver disease. Am J Med. 1987;83:77–82.PubMedCrossRef

120.

Chiolero R, Tappy L, Gillet M, Revelly JP, Roth H, Cayeux C, et al. Effect of major hepatectomy on glucose and lactate metabolism. Ann Surg. 1999;229:505–13.PubMedPubMedCentralCrossRef

121.

Tapia P, Soto D, Bruhn A, Alegria L, Jarufe N, Luengo C, et al. Impairment of exogenous lactate clearance in experimental hyperdynamic septic shock is not related to total liver hypoperfusion. Crit Care. 2015;19:188.PubMedPubMedCentralCrossRef

122.

Schmidt LE, Larsen FS. Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure. Crit Care Med. 2006;34:337–43.PubMedCrossRef

123.

Hernandez G, Luengo C, Bruhn A, Kattan E, Friedman G, Ospina-Tascon GA, et al. When to stop septic shock resuscitation: clues from a dynamic perfusion monitoring. Ann Intensive Care. 2014;4:30.PubMedPubMedCentralCrossRef

Titel: The value of blood lactate kinetics in critically ill patients: a systematic review
verfasst von: Jean-Louis Vincent
Amanda Quintairos e Silva
Lúcio Couto Jr
Fabio S. Taccone
Publikationsdatum: 01.12.2016
Verlag: BioMed Central
Erschienen in: Critical Care / Ausgabe 1/2016
Elektronische ISSN: 1364-8535
DOI: https://doi.org/10.1186/s13054-016-1403-5

Neu im Fachgebiet AINS

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

The value of blood lactate kinetics in critically ill patients: a systematic review

Abstract

Background

Methods

Results

Conclusions

Background

Methods

Results

General ICU patients

Observational studies

Interventional studies

Surgical patients

After cardiac surgery

Trauma patients

Observational studies

Interventional studies

Patients with sepsis

Observational studies

Interventional studies

Patients with cardiogenic shock

After cardiac arrest

Patients with acute respiratory failure

Other conditions

Discussion

Conclusion

Abbreviations

Acknowledgements

Funding

Availability of supporting data

Authors’ contributions

Competing interests

Neu im Fachgebiet AINS

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Hochrisiko-Eingriffe für postoperative Übelkeit

Diclofenac-Gel versus Ibuprofen bei akuten Rückenschmerzen

Update AINS

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Background

Methods

Results

General ICU patients

Observational studies

Interventional studies

Surgical patients

After cardiac surgery

Trauma patients

Observational studies

Interventional studies

Patients with sepsis

Observational studies

Interventional studies

Patients with cardiogenic shock

After cardiac arrest

Patients with acute respiratory failure

Other conditions

Discussion

Conclusion

Abbreviations

Acknowledgements

Funding

Availability of supporting data

Authors’ contributions

Competing interests

Consent for publication

Ethics approval and consent to participate

Weitere Artikel der Ausgabe 1/2016

Do spontaneous and mechanical breathing have similar effects on average transpulmonary and alveolar pressure? A clinical crossover study

Early identification of sepsis in hospital inpatients by ward nurses increases 30-day survival

Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study

The involvement of regulatory non-coding RNAs in sepsis: a systematic review

High urinary excretion of kidney injury molecule-1 predicts adverse outcomes in acute kidney injury: a case control study

Anemia management after acute brain injury

Neu im Fachgebiet AINS

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Hochrisiko-Eingriffe für postoperative Übelkeit

Diclofenac-Gel versus Ibuprofen bei akuten Rückenschmerzen

Update AINS